metformina arena 850 mg
arena group s.a. - romania - metforminum - compr. - 850mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformina arena 1000 mg
arena group s.a. - romania - metforminum - compr. - 1000mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformin accord 500 mg
wessling hungary kft. - ungaria - metforminum - compr. cu elib. prel. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformin teva 1000 mg
teva gyogyszergyar zrt.(teva pharm. works private) - ungaria - metforminum - compr. film. - 1000mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformin teva 500 mg
teva gyogyszergyar zrt.(teva pharm. works private) - ungaria - metforminum - compr. film. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
salcrozine 1000 mg
faes farma s.a. - spania - mesalazinum - compr. gastrorez. - 1000mg - medicamente antiinflamatoare intestinale acid aminosalicilic si alte medicamente similare
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
metformin bluefish 500 mg
bluefish pharmaceuticals ab - metforminum - compr. film. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformin bluefish 850 mg
bluefish pharmaceuticals ab - metforminum - compr. film. - 850mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformin bluefish 1000 mg
bluefish pharmaceuticals ab - metforminum - compr. film. - 1000mg - antidiabetice orale si parenterale, exclusiv insuline biguanide